
Please try another search
Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia. It operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. The company engages in the development of cannabidiol and hemp products for consumers; and development and distribution of therapeutics medicinal cannabis products based on good manufacturing practice certified cannabis extracts for medical markets. The company was formerly known as Bod Australia Limited and changed its name to Bod Science Limited in December 2022. Bod Science Limited was incorporated in 2014 and is based in Sydney, Australia.
Name | Age | Since | Title |
---|---|---|---|
Johannes Jacobus Cappon | - | 2021 | Director |
Nick Burgess | - | 2017 | Member of Medical Advisory Board |
Craig Weller | - | 2017 | CTO & Member of Medical Advisory Board |
Stella Valenzuela | - | 2017 | Member of Medical Advisory Board |
Iain McGregor | - | 2020 | Member of Medical Advisory Board |
Ian Olver | - | 2020 | Member of Medical Advisory Board |
Akash Bedi | 40 | 2019 | Non-Executive Director |
George Livery | 57 | 2018 | Non-Executive Director |
Arman Sabet | - | 2020 | Member of Medical Advisory Board |
Andrew McLachlan | - | 2020 | Member of Medical Advisory Board |
David Lewis Baker | 68 | 2022 | Non-Executive Chairman |
Joanne Patterson | - | 2017 | CEO, Company Secretary, Executive Director & Member of Medical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review